PMA device
Prostatron
Urologix, Inc. · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ, Class III) · First FDA decision Apr 13, 2000, newest Feb 18, 2005Enlarged prostate (BPH)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Prostatron"
MAUDE reports
0
Brand "Prostatron", since 2015
PubMed studies
63
Mentioning "Prostatron"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prostatron
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- PROSTATRONPMA supplement
P950014-S023 · Decided Feb 18, 2005 · 141 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- PROSTATRON (TM) SYSTEM DISPOSABLE TREATMENT APPLICATORPMA supplement
P950014-S021 · Decided Sep 19, 2001 · 79 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- PROSTATRONPMA supplement
P950014-S020 · Decided Apr 13, 2000 · 139 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prostatron", any status and sponsor, newest update first.
No registered device study names "Prostatron".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prostatron", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MEQ
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0345-04 · Started Dec 10, 2003 · Posted by FDA Jul 20, 2004
Reason given: During treatments, using the Prostatron units, the devices' Temperature Sensing System may change the rectal temperature reading by up to 2 degrees Celsius and may briefly delay updates to the rectal temperature reading.
Cause as FDA categorized it: Other · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
Published research
The most relevant PubMed records for "Prostatron"[tiab]. The summary above synthesizes these.
- Long-term effects of transurethral microwave thermotherapy.
Ohigashi T, Baba S, Ohki T, et al. · Int J Urol · 2002
- Case selection for high-energy transurethral microwave thermotherapy.
Tubaro A, d'Ancona FC · World J Urol · 1998
- Contrasting heating patterns and efficiency of the Prostatron and Targis microwave antennae for thermal treatment of benign prostatic hyperplasia.
Larson TR, Blute ML, Tri JL, et al. · Urology · 1998Comparative Study
- Long-term follow-up of transurethral microwave thermotherapy.
Lau KO, Li MK, Foo KT · Urology · 1998Clinical Trial
- Transurethral thermotherapy using the Prostatron device.
de la Rosette JJ, Blute ML, Desgrandchamp F · World J Urol · 1998Review
- [Transurethral microwave thermotherapy for benign prostatic hyperplasia: clinical evaluation with International Prostate Symptom Score (I-PSS)].
Arai Y, Onishi H, Terai A, et al. · Hinyokika Kiyo · 1993English Abstract
- Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.
Ahmed M, Bell T, Lawrence WT, et al. · Br J Urol · 1997Clinical Trial, Comparative Study
- High-energy microwave thermotherapy in the treatment of benign prostatic hyperplasia.
Cavarretta L, Scremin E, Cucciarrè G, et al. · Urol Int · 2003
- In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.
Huber PR, Mattarelli G, Strittmatter B, et al. · Prostate · 1995Comparative Study
- Current status of thermotherapy of the prostate.
de la Rosette JJ, D'Ancona FC, Debruyne FM · J Urol · 1997Review
- Transurethral microwave thermotherapy: clinical results after 11 years of use.
Vesely S, Knutson T, Dicuio M, et al. · J Endourol · 2005Comparative Study
- The prostatron transurethral microwave device in the treatment of bladder outflow obstruction due to benign prostatic hyperplasia.
Kirby RS, Williams G, Witherow R, et al. · Br J Urol · 1993
Other devices of this type
Also filed under product code MEQ.
- Urologix Targis SystemUrologix, LLC · PMA 2015
- Prolieve Thermodilatation SystemMedifocus, Inc. · PMA 2007
- TMX-2000 BphBoston Scientific Corp · PMA 2004
- Prostalund Coretherm System and Prostaland Coretherm AccessoriesProstalund AB · PMA 2014
- Prolieve Thermodilitation SystemMedifocus, Inc. · PMA 2011
- Coretherm System Microwave ThermotherapyProstalund AB · PMA 2009
- Prolieve Thermodilation SystemMedifocus, Inc. · PMA 2018
- Urologix Prostatron SystemUrologix, Inc. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.